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Abstract
A link has been established between prenatal nutrition and the development of metabolic and cardiovascular diseases later
in life, a process referred to as developmental programming. It has been suggested that the trajectory of development is
shifted by alterations in the maternal nutritional state leading to changes in developmental plasticity, in part underpinned
by epigenetic changes in gene regulation. However, to date, only candidate gene approaches have been used to assess
expression and molecular changes in the offspring of maternally undernourished animals. Furthermore, most work has
focused on animals at an age where the programmed phenotype is already manifest and little is known about changes in
gene expression in the offspring prior to development of obesity and related metabolic disorders. Gene expression profiles
of liver, retroperitoneal white adipose fat, and biceps femoris skeletal muscle tissue from young adult male rats (55 days old)
in which nutritional status had been manipulated in utero by maternal undernutrition (UN) were compared to the profiles of
offspring of ad libitum fed mothers serving as the control group (AD) (8 offspring/group). The expression profiles were
determined using the Illumina RatRef-12 BeadChip. No significant changes in expression were identified for skeletal muscle
or white adipose tissue. However, studies of liver tissue showed 249 differentially expressed genes (143 up regulated, 106
down regulated). Although the animals at day 55 have yet to develop obesity they already show biochemical abnormalities
and by day 110 express a phenotype characterized by increased adiposity and altered insulin sensitivity. An analysis of
pathways affected suggests that intrauterine programming of UN animals to favor fat as an energy source results in
mitochondrial dysfunction which initially affects the postnatal hepatic function and subsequently, via the resultant
metabolic changes in other organs leads to the evolution of a phenotype similar to that of the metabolic syndrome.
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Introduction
Developmental plasticity is the process by which environmental
factors acting during critical windows in early life affect the
developmental trajectory and thus the mature phenotype. Such
changes are often irreversible and are generally considered to be
underpinned at least in part by epigenetic processes [1,2]. While
adaptive in origin developmental plasticity can have maladaptive
consequences [3] and thus in humans can affect health [4].
The developing fetus is completely dependent on its mother and
so it follows that maternal nutrition during pregnancy, in
particular, has a strong influence on the intrauterine environment.
The DOHaD (Developmental Origins of Health and Disease)
hypothesis proposes that the metabolic syndrome (i.e. coronary
heart disease, type 2 diabetes, stroke, hypertension) originates
through developmental plasticity in response to undernutrition
during fetal life and infancy [1,5,6]. It has been hypothesized that
these diseases of later life arise from a mismatch [7] between the
actual postnatal environment and that predicted by the fetus
during the phase of developmental plasticity [8,9]. A variety of
maternal nutritional manipulations in the rat have induced
offspring who develop obesity, insulin resistance, and endothelial
dysfunction in later life including global maternal undernutrition
as used in this study [10] and maternal low protein by isocaloric
diets [11].
The mechanistic basis of such changes is only now being
explored. It has been proposed that epigenetic modifications of the
fetal genome establish new patterns of gene expression that reset
the metabolic state that is maintained into adulthood [12]. Effects
on candidate genes using such rat models have focused on genes
known to be significant in the metabolic syndrome including
peroxisomal proliferator-activated receptor (PPARa) and the
glucocorticoid receptor (GR) [11,13,14]. These observations
suggest that there are methylation differences in the promoters
of these genes and changes in mRNA levels between the offspring
of normally and undernourished mothers. A broader picture of the
cellular functions and genetic pathways that may be implicated
can be obtained using a non-biased, global microarray approach
to study gene expression in key tissues between offspring of control
and undernourished mothers.
In the present study, an established rat model of balanced
maternal undernutrition [10] has been used for investigation of
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gene expression differences in target tissues (liver, retroperitoneal
white adipose fat, and biceps femoris skeletal muscle) between
offspring of control and undernourished mothers. We studied
young adult rats at day 55 of age when they have not yet
developed the abnormal phenotype in order to identify any gene
expression changes that may play a role in predisposing these
animals to the development of the metabolic syndrome. The
findings show that no significant gene expression changes are
detected between the two groups in skeletal muscle and white
adipose tissue. However, the liver reveals 249 significant gene
expression differences (p,0.05) showing significant down regula-
tion of expression of several key genes affecting the entry of glucose
into the cell and its metabolism via the glycolytic and tricarboxylic
acid pathways. This would result in a substantial impairment in
their ability to utilize carbohydrate on restoration of a normal diet.
In addition, there was a marked increase in expression of genes
associated with the intracellular trafficking of fatty acids, their
peroxisomal degradation and their entry into the mitochondrion
to undergo b-oxidation. This might suggest that following
intrauterine undernutrition these animals have lost the flexibility
to switch between carbohydrate and fat as energy sources. The
analysis also reveals a substantial impairment of the electron
transport chain as evidenced by a down regulation in expression of
3 components of complex I and the ATP synthase that generates
ATP from the proton gradient. There is also a deficit in expression
of a key enzyme in the biosynthesis of the NAD proton carrier.
We suggest that maternal undernutrition leads to offspring that
favor fat as an energy source thus resulting in mitochondrial
dysfunction that initially affects postnatal hepatic function and
subsequently, other organs.
Materials and Methods
Animals
This study exploited a well defined model of developmental
programming via maternal undernutrition [10,15]. Briefly, virgin
Wistar rats (age, 10065 days) were time mated using a rat estrous
cycle monitor to assess the stage of estrous of the animals before
introducing the male. After confirmation of mating, rats were
housed individually in standard rat cages with free access to water.
All rats were kept in the same room with constant temperature
maintained at 25uC and a 12-h light/12-h darkness cycle.
Animals were assigned to one of two nutritional groups: a)
undernutrition (30% of ad libitum) of a standard chow diet
throughout gestation (UN group), b) standard chow diet ad libitum
throughout gestation (AD group). Food intake and maternal
weights were recorded daily until the end of pregnancy. After
birth, pups were weighed and litter size was adjusted to 8 pups per
litter to assure adequate and standardized nutrition until weaning.
Pups from undernourished mothers were cross-fostered onto
dams that had received AD feeding throughout pregnancy. At
weaning (day 22), animals were weight matched within maternal
dietary group to 2 animals per cage. Eight animals per group were
culled at day 55 following an overnight fast to represent an age
known to precede the development of increased adiposity and
altered insulin sensitivity in UN offspring. Tissues (liver,
retroperitoneal white adipose fat, and biceps femoris skeletal
muscle) were immediately dissected and snap-frozen in liquid
nitrogen for molecular analysis. A subcohort of animals (n = 8 per
group) were maintained until postnatal day 110 to represent an
age where phenotypic changes in growth and metabolism
between AD and UN offspring have previously been reported.
[10,16] The Animal Ethics Committee of The University of
Auckland approved all animal manipulations.
Phenotypic Measurements
Serial dual-energy x-ray absorptiometry (DEXA) analysis was
performed on the animals at day 55 and day 110 to establish body
composition and assessment of bone parameters. In addition to
DEXA, body adiposity was assessed via standard techniques (fat
depot dissection and weighing) following post-mortem. Body
weight and food and water intake were monitored. Plasma analysis
incorporated IGF-1, insulin, C-peptide, and lipid profiles.
Statistical analyses were performed with the Knowledge Discovery
Environment (InforSense Ltd., London, UK) statistical package.
Differences between groups were determined by a T-test for
difference in variance with an FDR correction, and data are
shown as an adjusted p-value6standard error.
Microarray Hybridization and Analysis
Global gene expression analysis was performed using the
Illumina Bead Array Platform. Briefly, total RNA was isolated
from cells with TRIzol reagent (Invitrogen, Paisley, Scotland, UK)
followed by column purification (RNeasy, Qiagen, UK). RNA
quality was assessed with the Lab-on-a-chip system (Agilent, Palo
Alto, CA). The RNA samples were amplified following the
Illumina TotalPrep RNA amplification protocol. The fluorescent
labeling and hybridization of RNA samples were also performed
according to custom protocols defined in the manufacturer’s
instructions. The samples from liver, skeletal muscle, and white
adipose fat tissue for male offspring (n = 8) were hybridized to the
RatRef-12 BeadChip available from Illumina (sampling 21,290
genes from the rat transcriptome). The hybridization signals were
captured and quantified using a Bead Array scanner and the
associated Bead Studio software. Bead Studio includes a spectrum
of internal controls for determining data quality. These check for
consistency in signal intensity, expected background and noise
levels, mismatches versus perfect matches, and signal in house-
keeping genes (Figure S1A-S1H). Data was exported and
normalization was performed in R (Bioconductor) using the
Limma [17] and Lumi [18] Bioconductor packages for microarray
analysis. Data was filtered for those showing expression on at least
one array and a variance-stabilizing transformation [19] was done
to take advantage of the multiple technical replicates (on average
20–30 per array) for each gene available on each Illumina chip.
Quantile normalization was chosen to remove technical variability
between arrays. Density plots of intensity and box plots of
amplitude were used to visualize the raw data compared to the
filtered and normalized data (Figure S2A-S2D). Limma was used
for pairwise comparisons between AD and UN using a linear
model to compute p-values, which were adjusted using the
Benjamini and Hochberg multiple testing correction. The
derivation of the p-value reflects the degree of variance between
biological replicates and thus is a measure of the confidence in
assigning significance of small fold changes in gene expression.
Genes with a p-value,0.05 were considered to be significantly
differentially expressed. Gene ontology analysis was done using
DAVID: Database for Analysis, Visualization, Integrated Discov-
ery [20] and Ingenuity Pathway Analysis software (Ingenuity,
Stanford USA).
Quantitative Real-Time PCR
The comparative expression levels in AD and UN RNA of
seven genes identified as differentially expressed from our
microarray data were verified by qRT-PCR, together with the
expression levels of five genes not present on the array. Cyclophilin
was used for the generation of a standard curve and normalization
of the RNA concentration. Each qRT-PCR was performed in
triplicate. Real-time RT-PCR was performed in 96-well white
Rat Gene Profiling Changes
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plates (Abgene) using the Verso SYBR Green 2-Step qRT-PCR
Fluorescein Kit (Thermo Scientific, UK) according to the
manufacturer’s protocols; the resulting fluorescence was quantified
using an iCycler system (Bio-Rad). The threshold cycle value (CT)
was obtained for each well as the cycle number at which the
measured fluorescence crossed the arbitrary threshold of 150 units
(all values are in log phase). The average CT was calculated for
each gene in each sample. Data were normalized to cyclophilin,
with DCT calculated as follows: DCT = CT(test)2CT(cyclophilin).
DDCT values were then calculated as the change in DCT for the
UN sample relative to the DCT value for the AD sample using the
equation: DDCT =2
CT(test)22CT(cyclophilin). This data is plotted in
Figure 1 and primer sequences are shown in Table S1.
Results
Phenotypic Assessment
For each of the 8 animals in each of the AD and UN groups, a
series of phenotypic measurements relevant to the metabolic
syndrome was recorded at day 55 (Table 1), the age at which gene
expression analysis was performed, and in a subcohort of animals
at day 110 (Table 2). From these measurements, it is clear that at
day 55 there are very few differences in key indicators (insulin
resistance, glucose intolerance, elevated blood lipids and increased
adiposity) as might be expected at this early stage in the
progression of the metabolic syndrome. However, by day 110
there are clear indications of abnormalities in insulin sensitivity
and markers of adiposity including total fat mass and plasma leptin
concentrations.
Expression Analysis
Expression profiling was done for liver, white adipose fat, and
skeletal muscle tissue from young adult (55-day-old) male rats born
to either AD or UN dams. In each group there were eight
biological replicates, all of which were raised postnatally on an ad
libitum diet. Expression profiles were determined using the Illumina
RatRef-12 BeadChip that permits interrogation of 21,290 rat
genes. Genes with a p-value,0.05 were considered to show
significant differential expression between the two groups. Using
these criteria, no significant gene expression changes between the
two groups were identified for skeletal muscle or white adipose
tissue in the day 55 animals. However, the comparison for liver
revealed a list of 249 differentially expressed genes. Table S2
summarizes the expression values for all genes represented on the
array and Table S3 the list of 249 differentially expressed genes
with associated p-values and fold changes between the two groups.
Figure 1. qRT-PCR for Microarray Verification. QRT-PCR for the two treatments was run in triplicate with cyclophilin as a control. The DDCT
values are shown for each gene along with error bars for standard error. (A) Seven genes were chosen from the 249 significantly differentially
expressed genes on the Illumina microarray. The RNA from the 8 biological replicates was pooled for each of the two treatment groups. In Table 2,
the DDCT values have been converted into a fold change for comparison to the array results. (B) Five Previously Published Candidate Genes from
Lillycrop et al. [11] were analyzed be qRT-PCR. Each of the eight individual samples was run in triplicate (24 data points for each treatment group).
Due to the large number of data points, the error bars are very small and difficult to see.
doi:10.1371/journal.pone.0007271.g001
Table 1. Phenotype data, day 55 offspring.
AD
mean
UN
mean
Adjusted
p-value
Body weight (grams) 282.38 234.50 0.001
Body length (mm) 203.63 192.63 0.005
Liver weight (% body weight) 3.65 3.02 0.014
Spleen weight (% body weight) 0.32 0.27 NS
Heart weight (% body weight) 0.36 0.71 NS
Fat pad weight (% of body weight) 0.80 0.59 0.039
Plasma glucose (mmol/l) 6.24 6.67 NS
Urea (mmol/l) 4.76 6.18 0.010
Free Fatty Acids (mmol/l) 0.79 0.68 NS
Glycerol (mmol/l) 0.21 0.19 NS
Total Protein (g/DL) 5.45 5.39 NS
Lipase (U/l) 9.10 9.06 NS
C-Peptide (pg/ml) 132.18 162.85 NS
Triglycerides (mmol/l) 0.78 0.77 NS
IGF-1 (ng/ml) 1221.50 1277.63 NS
Creatinine (mmol/l) 20.15 23.64 NS
Insulin (ng/ml) 0.33 0.53 NS
Total Fat (%) 24.09 23.66 NS
LDL (mmol/l) 0.27 0.46 0.006
HDL (mmol/l) 1.27 1.34 NS
LDL:HDL ratio 0.21 0.35 0.003
Phenotypic measurements relevant to metabolic syndrome measured for each
of the eight animals in each treatment group at day 55. The p-value was
calculated with a t-test and an FDR correction. NS = not significant.
doi:10.1371/journal.pone.0007271.t001
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Quantitative RT-PCR (qRT-PCR) Analysis of Selected
Genes. In order to confirm the expression data derived from
array analysis, seven genes (IGFBP2 (NM_013122), FABP7
(NM_030832), Zfand2a (NM_001008363), DGAT2 (XM_574498),
GYS2 (NM_013089), ADRA1B (NM_016991), and RBP1
(XM_230637)) found to be differentially expressed were selected
for qRT-PCR on the pooled RNA samples for the biological
replicates in each treatment group. Cyclophilin was used as an
invariant control for normalization. Figure 1A summarizes the
data and illustrates that the differences in DDCt values between
the AD and UN RNA populations for each gene are consistent
with the expression changes determined by array analysis. These
values were then converted to fold change to directly compare the
qRT-PCR values to the expression values from the microarray
(Table 3).
Previous analysis has provided evidence that the expression of
the PPARa, GR and AOX (acyl-CoA oxidase) genes is altered in
the liver of offspring from normally nourished mothers compared
to mothers who had either a low protein diet or balanced
undernutrition during pregnancy [11,21]. It has also been
suggested that PEPCK (phosphoenolpyruvate carboxykinase)
and 11b-HSD2 (11b-hydroxysteroid dehydrogenase type 2) may
also be genes influenced by diet [22,23]. As these genes were not
represented by any of the oligonucleotides on the RatRef-12 array,
they were assessed by qRT-PCR in the AD and UN RNA
populations using cyclophilin as the normalization control. The
findings are shown in figure 1B for the 8 biological replicates in
each treatment group. For PPARa and PEPCK, there is no
evidence for any differences in expression levels between the two
treatment groups. However, GR, AOX and 11b-HSD2 show
between 1.5 to 2-fold increases in expression in the UN treatment
group.
Discussion
Animals at postnatal day 55 were chosen for gene expression
analysis because they had completed puberty but had not begun to
exhibit the features of the metabolic syndrome phenotype as
observed later in adulthood and, as shown in the present study, as
early as day 110 postnatally [10,24]. Our results presented show
that while there are differences in gene expression in hepatic tissue
in day 55 males, there are no observed differences in white adipose
fat or skeletal muscle. This is an intriguing finding, as both fat and
skeletal muscle is adversely affected in the adult. This suggests that
there is a cascade of biological processes that amplifies over time to
lead to the phenotypic abnormalities. Previously Ozanne et al. [25]
has shown, in a different but related experimental model of
maternal low protein intake, that the expression of a limited
number of genes in skeletal muscle is minimal early in life and
accumulates later in life. It would appear that major changes in
gene expression in the liver precede those in other metabolically
relevant tissues.
The data for all three tissues is derived from 8 biological
replicates in each treatment group with technical replication on
each array varying from 20–30 fold. This means that for each gene
represented on the array, there are between 160 and 240
measurements of expression level. This permits an accurate
estimate of the variance that is used to derive the final p-value
and provides confidence in the detection of small gene expression
changes. Thus the changes found in liver are based on many
measurements and are highly significant. This is further
underscored by the absence of any significant changes in gene
expression between the two groups in skeletal muscle or white
adipose fat tissue subjected to the same analysis. The qRT-PCR
analysis of candidate genes (PPARa and PEPCK) showed very
little difference in expression levels between the two groups in the
day 55 male offspring. This contrasts with the 10-fold, 3-fold and
3-fold increase for PPARa, GR and AOX, respectively, in the day
34 offspring born to nutritionally restricted mothers as reported by
Lillycrop et al. [11]. Four factors may explain this difference. First,
the restricted diet is different (50% protein restriction only)
whereas the diet in the study reported here is 30% of normal chow
for all nutrients and may impact differently on gene expression.
Second, in the Lillycrop et al. study the animals were weaned on
day 28 and spent only 6 days in the post-weaning period compared
to 33 days in this present study. Third, the composition of the post-
weaning diet in the present study is grain-based as opposed to a
purified diet containing 50% sucrose in the Lillycrop et al. study.
Finally, the male and female tissues were pooled in the Lillycrop et
al. study and there may be gender differences we have not
explored. Similar to previous reports, GR, 11b-HSD2 and AOX
show increases of between 1.5 to 2-fold in the offspring of
undernourished mothers used in this study [11].
Table 2. Phenotype data, day 110 male offspring.
AD
mean
UN
mean
Adjusted
p-value
Body weight (grams) 511 489 NS
Body length (mm) 238 218 0.05
Total Fat (%) 27.8 35.6 0.05
Fat pad weight (% of body weight) 1.45 2.14 0.05
Leptin (ng/ml) 9.6 22.5 0.005
Insulin (ng/ml) 0.260 0.502 0.001
C-Peptide (pg/ml) 466 729 0.05
Plasma glucose (mmol/l) 7.0 7.2 NS
Free Fatty Acids (mmol/l) 0.86 0.99 NS
Liver weight (% body weight) 2.92 2.78 NS
IGF-1 (ng/ml) 1236 1145 NS
Phenotypic measurements relevant to metabolic syndrome measured for each
of the eight animals in each treatment group at day 110. The p-value was
calculated with a t-test and an FDR correction. NS = not significant.
doi:10.1371/journal.pone.0007271.t002
Table 3. Fold Change Values Comparing Microarray and QRT-
PCR.
Gene
Symbol
Genbank
Accession
Number
Microarray
Expression
(Fold Change)
QRT-PCR
Expression
(Fold Change)
ADRA1B NM_016991.2 0.735 1.932
DGAT2 XM_574498.1 0.764 0.494
FABP7 NM_030832.1 1.381 1.682
GYS2 NM_013089.1 1.541 1.606
IGFBP2 NM_013122.1 2.144 2.732
Zfand2a NM_001008363.1 1.492 2.549
RPB1 XM_230637.3 1.631 1.217
Fold change for the QRT-PCR data and the Illumina expression data is compared
for each of the seven genes from the Illumina arrays that were analyzed by QRT-
PCR. Fold changes for the RT-PCR reflect directly the DDCt values between the
two groups after normalization.
doi:10.1371/journal.pone.0007271.t003
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Analysis of the gene categories and associated pathways
associated with differentially expressed genes (Table S3) has
revealed some relevant changes that potentially impact on the
metabolic phenotype. Table 4 summarizes the relevant categories
to emerge from analysis of gene functions (some of which emerged
from DAVID and Ingenuity analyses) associated with the list of
differentially expressed genes. Figure 2A and 2B summarize the
interrelationships between pathways involved in glucose, fat, and
energy metabolism and highlight differentially regulated genes that
influence these pathways.
Glucose Metabolism
In utero the fetus relies mainly on maternal glucose for its energy
supply and only in late gestation develops the capacity for glucose
storage and mobilization and for gluconeogenesis in preparation
for postnatal life. Glucose and glycogen metabolism appear to
have developed inappropriately in the livers of UN animals
[26,27]. Many of the changes in hepatic gene expression we
detected are relatively modest and this may reflect alterations in
hepatic development. Burns et al. reported changes in the balance
of periportal to periarterial hepatocytes which have different
metabolic profiles in the offspring of low protein fed dams [28].
The livers of UN animals show changes in the anomalous
expression of RNA for several enzymes involved in glycogenesis,
glycogenolysis and glycolysis. There is a 54% increase in the
expression of the glycogen synthase gene (GYS2), however, this is
counterbalanced by a marked decrease in expression of glucan
branching enzyme (GBE1) that is essential for the formation and
storage of glycogen. Furthermore, there is a modest decrease in
phosphoglucomutase (PGM1) that converts the glucose-1-phos-
phate resulting from glycogenolysis to glucose-6-phosphate
destined for glycolysis. There is also a deficit of triose phosphate
isomerase that could result in an inefficient conversion of fructose
1–6 bisphosphate to glyceraldehyde-3 phosphate in the glycolytic
process. The reduced expression of triose phosphate isomerase
would therefore affect the efficiency of glucose conversion to
pyruvate and might indicate an increased accumulation of
dihydroxyacetone phosphate. This can readily be reduced to
glycerol-3-P that is the backbone for phosphatidates and signaling
phospholipids. Overproduction of these could disrupt intracellular
function. The efficiency of the citric acid cycle (TCA) would be
compromised by the reduction in dehydrogenase E1 (DHTKD1).
This enzyme catalyses the conversion of a-ketoglutarate to
succinyl CoA- a key step in the TCA. Its subsequent conversion
to succinate is the only step in glucose catabolism that produces
high-energy phosphate (GTP) directly, without the need for
oxidative phosphorylation. The GTP can be used for nucleotide-
specific metabolic reactions or it can convert ADP to ATP.
Production of oxaloacetate further on in the cycle would also be
affected. This would slow the rate of formation of citric acid and
the entry into the TCA of acetyl-CoA from oxidative decarbox-
ylation of pyruvate. Supplementation of oxaloacetate from
metabolism of branched-chain amino acids would also be reduced.
This means that most of the oxaloacetate is required as an
intermediate for TCA function and less is available for
gluconeogenesis. It is interesting to note that there is a reduction
in the transcripts of other enzymes involved in the catabolism of
amino acids that supply intermediates to the TCA cycle. In the
fetus, this impasse may be circumvented to an extent by the
presence of the glyoxalate cycle in which acetate can be converted
to either glucose or succinate. However, this pathway disappears
after birth and hence the inability for gluconeogenesis would be
exacerbated postnatally.
Insulin and IGF-1 Signalling
The insulin and IGF-1 receptors are closely related structurally
and share many post-receptor signaling mechanisms. The livers
of UN animals show changes in expression of genes whose
products are known to attenuate the PI3 kinase signaling
pathway that is common to both receptors. Both IGFBP2 and
Rbp1 are known to interact with components of the PI3Kinase/
Akt signaling pathway IGFBP2 is likely to act by sequestering
IGF-1 and preventing binding to its receptor and hence
inhibiting downstream activation of PI3K [29]. Rbp1 has been
shown to interfere with the heterodimerization of the p85/p110
subunits of Akt [30]. This appears to be a retinoic acid
independent effect of Rbp1. An increase in expression of
Tribbles homolog 2 (TRB2) has been shown to interfere with
the phosphorylation step by PI3K that activates Akt, the effector
kinase of this signaling cascade. Conversely increased expression
of the protein tyrosine phosphatase (PTPRB) will increase the
rate of dephosphorylation of Akt to its inactive form. The
concerted effect of these gene expression changes is likely to have
the effect of blunting insulin signaling and increasing insulin
insensitivity. It is interesting to note that while there is not a
significant increase in the levels of circulating insulin, there is a
discernable upward trend in UN animals that could indicate the
initial stages in the establishment of insulin resistance. One of the
major targets of Akt is the insulin-dependent glucose transporter
GLUT4 that on activation migrates from the ER to the plasma
membrane and facilitates glucose entry into the cell. An
additional perturbation of this process in UN animals is suggested
by the increased expression of p45/STRAP that has been shown
to interfere with GLUT4 [26,31] trafficking between the ER and
the cell membrane. Taken together these findings suggest that the
livers of UN animals have altered insulin sensitivity and glucose
homeostasis.
A primary function of IGF-1 is to drive postnatal cell
proliferation and growth, principally through the MAP kinase
signaling pathway. It is only present in low levels in the fetus
(where IGF-2 predominates) and increases dramatically in the
perinatal period. The liver is the major source of circulating IGF-
1. The actions of IGFs are modulated by the presence of a number
of binding proteins (IGFBPs), one of which IGFBP2, shows a .2
fold increase in expression in liver of UN animals. IGFBP2 is
secreted into the blood and is thought to have a negative effect on
IGF-1 activity. In this study, the highly significant reductions in
body length and body, spleen, and liver weights lend support to
this role. The levels of IGFBP2 have been shown to be high in the
early to mid-term fetus and then drop markedly towards term. The
persistence of elevated IGFBP2 in UN animals is therefore an
abnormality that could have a wide range of effects on postnatal
growth and organ development.
Mitochondrial Activity
The array analysis indicates a number of changes in the
expression of genes that could affect the efficiency of electron
transport and ATP generation in the mitochondrion in liver from
UN animals. Transcripts of NADH dehydrogenase subunits
(NDUFC2, NDUFB6 and NDUFA8) of complex I of the electron
transport chain are all reduced as is quinolate phosphoribosyl-
transferase (QPRT) required for the synthesis of NAD, the
electron carrier. In addition, the ATP synthase (ATP5o) that
generates ATP from the electron gradient is reduced by a similar
amount. Changes are also observed in peptidylprolyl isomerase D
(PPID) that controls the mitochondrial permeability transition
pore and TIM14, a component of the mitochondrial protein
import motor. Taken together these findings suggest a degree of
Rat Gene Profiling Changes
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mitochondrial dysfunction in the livers of UN animals that could
significantly affect the energy balance of the tissue and may be the
precursor of later adiposity. Since the liver acts as the initial
nutrient sensor, this defect could affect not only its own
metabolism but also that of other organs that respond to its
systemic signals.
Figure 2. Genes that Influence Glucose, Fat, and EnergyMetabolism Pathways and IGF-1 and PI3K Signaling Pathways. (A) Summarizes
the interrelationships between pathways involved in glucose, fat, and energy metabolism and highlights differentially regulated genes that influence
these pathways. (B) A summary of the genes that are altered in signaling through the IGF-1 and PI3K signaling pathways and their relevance to glucose
and fat metabolism. Normal arrows indicate no change in gene expression; dashed arrows indicate down regulation; bold arrows indicate up-regulation.
doi:10.1371/journal.pone.0007271.g002
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Fat
In this well-characterized model, it has been shown that
undernourishment of dams during pregnancy predisposes offspring
to later adiposity and hyperinsulinaemia when fed a normal diet [21]
but only at an age later than we have undertaken gene expression
analysis. In the present study, even as early as day 110, male offspring
of UN dams are showing features of the metabolic syndrome related
to increased adiposity and hyperinsulinemia and hyperleptinemia.
The absence of any differences in fat expression profiles between
control and UN animals at day 55 may suggest that the development
of adiposity is secondary to early metabolic perturbations in postnatal
life. It is interesting to note that at day 35 UN rats show the onset of a
sedentary phenotype (and hence reduced energy expenditure) before
the presence of obesity [32]. This may reflect early changes in
neurological gene expression modifying behaviour.
The elevated expression of RNA for fatty acid binding protein
(FABP7) suggests that in livers from UN animals there is an
increase in the intracellular trafficking of fatty acids. This is
paralleled by increases in expression of AOX (from qRT-PCR
analysis), which catalyses the first step in the peroxisomal
degradation of fatty acids, and carnitine acyltransferase (CRAT)
that shuttles fatty acids into the mitochondrial matrix. It is
interesting to note that the expression of the first enzyme in the
biosynthetic pathway of carnitine, trimethyllysine hydroxylase
(Tmlhe) is down regulated and this may reflect a homeostatic
response to excess fatty acid trafficking. These findings suggest that
more energy is derived from b-oxidation of fatty acids in these
animals. However, this can only be achieved if the NADH from b-
oxidation regenerates NAD and forms ATP. The observed defects
(especially in complex I) indicate a disruption in this process. The
provenance of these fatty acids is not clear since there were no
significant differences between treatment groups in the circulating
levels of either triglycerides or free fatty acids although LDL levels
are elevated by maternal undernutrition. Other possible sources of
fatty acids could be from increased endogenous synthesis or from
turnover of cellular components. There is no evidence from the
microarray analysis for an increase in enzymes for the latter;
indeed the modest decrease in levels of diacylglycerol acyltransfer-
ase (DFAT2) in UN animals would indicate a blunting of
triglyceride synthesis in liver.
The increased expression of SREBP cleavage activating protein
(SCAP) suggests that there may be higher levels of sterol synthesis
taking place in livers of undernourished animals. The formation of
a transcriptionally active sterol response element binding protein
(SREPB) involves the proteolytic action of SCAP [33]. In support
of these observations the levels of circulating LDL cholesterol in
the UN group is significantly elevated. Interestingly a 60%
increase in 11b-HSD2 transcripts was seen in the livers of UN
animals accompanied by a similar increase in the expression levels
of GR. 11b-HSD2 appears in late gestation/postnatal tissues in
human fetal tissues. [34] Elevated levels of this enzyme in the livers
of UN animals would be a mechanism to moderate the effects of
high levels of circulating corticosterone that may arise in response
to nutritional deprivation/stress.
Ribosomal Proteins and Protein Turnover
An intriguing finding of the analysis is an increase (in the range
7–24%) in transcripts in UN animals of 13 of 80 recognized
ribosomal proteins (79 of which are represented on the array by
multiple oligonucleotides) that occur in the large and small
ribosomal subunits. Eight of the proteins are components of the
mitochondrial ribosome. Similar increases in expression are also
seen in brix (BXDC1), involved in ribosome biogenesis, NPG1, a
nucleolar GTPase required for the maturation and nuclear export
of pre-ribosomes, and Cebpz, a gene important in the processing
of rDNA involved in the 60 s subunit [35]. These findings suggest
a greater degree of metabolic flux in ribosomes from UN animals,
however it is difficult to understand the significance of these
observations given the fact that on the basis of the current
annotation only about 16% of the ribosomal proteins show
changes in expression levels. It is possible that the increased
turnover of ribosomal proteins is contributing to the higher levels
of urea observed in the day 55 UN animals.
Effects on Gene Transcription
It is notable that a group of genes that influence transcription
show upregulation to varying extents. Some (such as the Gtf and
MED factors) have a general effect on the transcriptional
apparatus. The most notable increase is in the Rpb1 gene known
to be expressed highly in the liver, particularly in hepatic stellate
cells [36,37]. In liver Rpb1 has an important role in the
production of retinoid derivatives that activate the RAR and
RXR retinoic acid receptors [38]. RXR can heterodimerise with
the PPAR proteins to form active nuclear receptors that target
genes involved in fat metabolism and energy homeostasis; for
example Crat and AOX are shown to be upregulated in the UN
offspring. Thus elevated or abnormal Rbp1 expression may have a
major role in establishing the metabolic syndrome phenotype.
Two other genes show significant changes in gene expression
that may impact hepatic function. The first is Col14a1 (a member
of the collagen gene family) that was originally called undulin
[39,40]. This gene is expressed in hepatic stellate cells that have a
role in the formation of the hepatic extra cellular matrix [41] and
shows a 20% increase in gene expression. This may be a marker of
some underlying pathology as Col14a1 has been associated with
the rearrangement of connective tissue occurring in hepatic
fibrosis [39]. It is of note that Rbp1 expression changes have also
been associated with hepatic fibrosis [37] and thus the gene may
be involved in the regulation of Col14a1. The second gene is
Adra1b (adrenergic receptor alpha 1b showing a 79% upregula-
tion) that has been associated with carbohydrate metabolism in the
liver [42] and disruption of glucose homeostasis when the gene is
inactivated [43,44]. Given that the role of the receptor is to
stimulate glycogenolysis and the process of glycogen formation is
impaired in UN animals, the significance of increased expression is
not clear. This may reflect an irreversible change in response to
the intrauterine nutritional state or a postnatal compensatory
mechanism to the altered metabolic profile set in utero.
Conclusions
Studies to date have primarily focused on a candidate gene
approach in animals where the classical features of the metabolic
syndrome in the programmed phenotype are already evident.
There is a relative paucity of data on gene expression, either by
candidate or an array-based approach, on key tissues related to the
metabolic syndrome in animals at an age preceding development
of the metabolic phenotype. The gene expression changes in
appropriate pathways in the livers of the male offspring of
maternally undernourished dams at day 55 would suggest that
these animals may be predisposed to a persistent and perturbed
ability to coordinate fat and carbohydrate metabolism with a shift
to a use of fatty acids as an energy source. We have also shown
that these animals proceed to develop a phenotype similar to that
of the metabolic syndrome as early as postnatal day 110. Array
analysis of tissues at the day 110 time point was beyond the scope
of the present trial. However, although the present study cannot
directly correlate the observed gene expression changes at day 55
with the phenotype at day 110, it provides clear evidence of
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disturbed hepatic function in a number of key genes related to lipid
oxidation and mitochondrial function at a pre-phenotypic age.
There are parallels with the observations of Koves et al. [27] and
Sparks et al. [45] where diet induced obesity in adult life induces
oxidative stress associated with increased b-oxidation of fat
metabolism, impaired switching of carbohydrate substrates,
depletion of TCA cycle intermediates, and decreased expression
of components of the electron transport chain. They propose that
mitochondrial dysfunction may be driving the pre-diabetic insulin
resistant state. The observations in our rat model indicate that the
liver is irreversibly programmed to respond to a nutritionally
restricted environment and that this persists into early adulthood
(day 55). At this age, similar changes are not observed in adipose
tissue or skeletal muscle, suggesting that the liver can meet the
immediate energy requirements of these peripheral tissues and that
it manifests metabolic abnormalities in advance of the full
metabolic syndrome phenotype. These data have uncovered
potential candidate genes and pathways that when perturbed lead
to the development of the metabolic syndrome in older animals
and therefore provide a focus for more detailed gene-specific
studies.
Supporting Information
Table S1 PCR primer sequences used for the qRT-PCR
analysis
Found at: doi:10.1371/journal.pone.0007271.s001 (0.03 MB
XLS)
Table S2 Raw data for all Illumina Array Data after filtering
and normaization including annotation
Found at: doi:10.1371/journal.pone.0007271.s002 (7.06 MB
XLS)
Table S3 Log Fold Change, Adjusted p-value, Accession
Number, and Gene Symbol for the 249 differentially expressed
genes (p-value,0.05).
Found at: doi:10.1371/journal.pone.0007271.s003 (0.07 MB
XLS)
Figure S1 Illumina internal quality control measurements with
BeadStudio Software for all 48 arrays. (A) Arrays should have
signal intensities in the same range. There are three categories of
signal intensity: low, medium, and high. A linear increase from low
to medium to high is expected. (B) This image shows the individual
medium intensity values for each array. Arrays should have signal
intensities in the same range. (C) Compares the signal intensity of
two mismatches to the signal intensity of a perfect match. The
perfect matches should have a 3–4 fold higher signal. No signal
intensite would indicate a hybridization failed. (D) Shows the high
stringency of the data The biotin signal should be 3–4 fold lower
than the high stringency signal. (E) This image shows the data for
the negative control. The background signal should be approx-
imately 70. The noise signal should be very low for high quality
data. (F) This image compares the signal from the housekeeping
genes to the signal from all genes. As housekeeping genes are
always expressed they should have a much higher signal compared
to all genes.
Found at: doi:10.1371/journal.pone.0007271.s004 (1.28 MB TIF)
Figure S2 Visualization of Raw and Normalized Microarray
Data. Graphs are shown of raw data (A, B) and normalized (C, D)
data for each of the 64 microarrays. (A)Boxplot of the amplitude
for the array signal for the raw data. (B) Density plot of the
intensity of the raw data for each array. (C) Boxplot of the
amplitude for the array signal for the normalized data. (C) Density
plot of the intensity of the normalized data for each array.
Found at: doi:10.1371/journal.pone.0007271.s005 (2.22 MB TIF)
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